Cargando…
Éruption eczématiforme après le vaccin par Pfizer-BioNTech COVID-19()
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276112/ https://www.ncbi.nlm.nih.gov/pubmed/34272069 http://dx.doi.org/10.1016/j.therap.2021.04.012 |
| _version_ | 1783721850110476288 |
|---|---|
| author | Bekkali, Nihal Allard, Tanguy Lengellé, Céline Estève, Eric |
| author_facet | Bekkali, Nihal Allard, Tanguy Lengellé, Céline Estève, Eric |
| author_sort | Bekkali, Nihal |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8276112 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82761122021-07-14 Éruption eczématiforme après le vaccin par Pfizer-BioNTech COVID-19() Bekkali, Nihal Allard, Tanguy Lengellé, Céline Estève, Eric Therapie Lettre À La Rédaction Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. 2021 2021-04-29 /pmc/articles/PMC8276112/ /pubmed/34272069 http://dx.doi.org/10.1016/j.therap.2021.04.012 Text en © 2021 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Lettre À La Rédaction Bekkali, Nihal Allard, Tanguy Lengellé, Céline Estève, Eric Éruption eczématiforme après le vaccin par Pfizer-BioNTech COVID-19() |
| title | Éruption eczématiforme après le vaccin par Pfizer-BioNTech COVID-19() |
| title_full | Éruption eczématiforme après le vaccin par Pfizer-BioNTech COVID-19() |
| title_fullStr | Éruption eczématiforme après le vaccin par Pfizer-BioNTech COVID-19() |
| title_full_unstemmed | Éruption eczématiforme après le vaccin par Pfizer-BioNTech COVID-19() |
| title_short | Éruption eczématiforme après le vaccin par Pfizer-BioNTech COVID-19() |
| title_sort | éruption eczématiforme après le vaccin par pfizer-biontech covid-19() |
| topic | Lettre À La Rédaction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276112/ https://www.ncbi.nlm.nih.gov/pubmed/34272069 http://dx.doi.org/10.1016/j.therap.2021.04.012 |
| work_keys_str_mv | AT bekkalinihal eruptioneczematiformeapreslevaccinparpfizerbiontechcovid19 AT allardtanguy eruptioneczematiformeapreslevaccinparpfizerbiontechcovid19 AT lengelleceline eruptioneczematiformeapreslevaccinparpfizerbiontechcovid19 AT esteveeric eruptioneczematiformeapreslevaccinparpfizerbiontechcovid19 |